CD19 Antibody (clone C19/366)
LS-C389842
ApplicationsFlow Cytometry, ImmunoFluorescence
Product group Antibodies
ReactivityHuman
TargetCD19
Overview
- SupplierLifeSpan BioSciences
- Product NameCD19 Antibody (clone C19/366)
- Delivery Days Customer23
- Application Supplier NoteCD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.. Flo (0.5 - 1 µg/10E6 cells), IF (0.5 - 1 µg/ml) CD19 is a transmembrane glycoprotein that contains two extracellular immunoglobulin-like domains. CD19 is present in both benign and malignant B-cells and is considered to be the most reliable surface marker of this lineage over a wide range of maturational stages. In normal lymphoid tissue, CD19 is observed in germinal centers, in mantle zone cells, and in scattered cells of the inter-follicular areas. Anti-CD19 exhibits an overall immunoreactivity pattern similar to those of the antibodies against CD20 and CD22. However, in contrast to CD20, expression of CD19 is continuous throughout B-cell development and through terminal differentiation of B-cells into plasma cells. Anti-CD19 positivity is seen in the vast majority of B-cell neoplasms commonly at a lower intensity than normal B-cell counterparts. Plasma cell neoplasms are nearly always negative, as are T-cell neoplasms.
- ApplicationsFlow Cytometry, ImmunoFluorescence
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDC19/366
- Concentration0.2 mg/ml
- ConjugateUnconjugated
- Estimated Purity...
- Gene ID930
- Target nameCD19
- Target descriptionCD19 molecule
- Target synonymsB4, CVID3, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T-cell surface antigen Leu-12, differentiation antigen CD19
- HostMouse
- IsotypeIgG1
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC41116161




![FACS analysis of human peripheral blood lymphocytes using GTX01455-08 CD19 antibody [HIB19] (PE). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.25 μg (5 μl)](https://www.genetex.com/upload/website/prouct_img/normal/GTX01455-08/GTX01455-08_20200428_FACS100_w_23053121_847.webp)


